Callahan; James Francis
Patent Applications and Registrations
Patent applications and USPTO patent grants for Callahan; James Francis.The latest application filed is for "bisaryl heterocycles as nrf2 activators".
- Callahan; James Francis - King of Prussia PA
- Callahan; James Francis - Philadelphia PA
| Patent | Date |
|---|---|
| Bisaryl heterocycles as NRF2 activators Grant 11,117,905 - Callahan , et al. September 14, 2 | 2021-09-14 |
| Bisaryl amides as NRF2 activators Grant 11,078,216 - Callahan , et al. August 3, 2 | 2021-08-03 |
| Bisaryl Heterocycles As Nrf2 Activators App 20200062781 - CALLAHAN; James Francis ; et al. | 2020-02-27 |
| Nrf2 regulators Grant 10,485,806 - Kerns , et al. Nov | 2019-11-26 |
| Bisaryl Amides As Nrf2 Activators App 20190330238 - CALLAHAN; James Francis ; et al. | 2019-10-31 |
| Nrf2 REGULATORS App 20190224212 - Kerns; Jeffrey K. ; et al. | 2019-07-25 |
| NRF2 regulators Grant 10,272,095 - Kerns , et al. | 2019-04-30 |
| Calcilytic compounds Grant 9,227,914 - Marquis , et al. January 5, 2 | 2016-01-05 |
| Calcilytic Compounds App 20150183723 - MARQUIS; Robert W. ; et al. | 2015-07-02 |
| Calcilytic compounds Grant 8,980,950 - Marquis , et al. March 17, 2 | 2015-03-17 |
| Calcilytic Compounds App 20140057980 - Marquis; Robert W. ; et al. | 2014-02-27 |
| Calcilytic compounds Grant 8,586,631 - Marquis , et al. November 19, 2 | 2013-11-19 |
| Calcilytic Compounds App 20130158114 - Marquis; Robert W. ; et al. | 2013-06-20 |
| Calcilytic compounds Grant 8,399,517 - Marquis , et al. March 19, 2 | 2013-03-19 |
| Dual pharmacophores--PDE4-muscarinic antagonistics Grant 8,084,449 - Callahan , et al. December 27, 2 | 2011-12-27 |
| Dual pharmacophores--PDE4-muscarinic antagonistics Grant 8,071,588 - Callahan , et al. December 6, 2 | 2011-12-06 |
| Dual pharmacophores--PDE4-muscarinic antagonistics Grant 8,067,408 - Callahan , et al. November 29, 2 | 2011-11-29 |
| Calcilytic Compounds App 20110054021 - MARQUIS; ROBERT W. ; et al. | 2011-03-03 |
| Calcilytic compounds Grant 7,829,594 - Marquis , et al. November 9, 2 | 2010-11-09 |
| Novel Compounds App 20090239897 - BOEHM; JEFFREY CHARLES ; et al. | 2009-09-24 |
| Dual Pharmacophores - PDE4-Muscarinic Antagonistics App 20090203677 - Callahan; James Francis ; et al. | 2009-08-13 |
| Dual Pharmacophores - PDE4-Muscarinic Antagonistics App 20090203657 - Callahan; James Francis ; et al. | 2009-08-13 |
| Dual Pharmacophores - PDE4-Muscarinic Antagonistics App 20090197871 - Callahan; James Francis ; et al. | 2009-08-06 |
| Calcilytic Compounds App 20090163589 - Marquis; Robert W. ; et al. | 2009-06-25 |
| Compounds Grant 7,550,480 - Boehm , et al. June 23, 2 | 2009-06-23 |
| Calcilytic compounds Grant 7,514,473 - Marquis , et al. April 7, 2 | 2009-04-07 |
| Novel Compounds App 20090069318 - Callahan; James Francis ; et al. | 2009-03-12 |
| Chemical Compounds App 20080262040 - Callahan; James Francis ; et al. | 2008-10-23 |
| Process For Preparing Pyrido[2,3-D]Pyrimidin-7-One And 3,4-Dihydropyrimido{4,5-D}Pyrimidin-2(1H)-One Derivatives App 20080096905 - Callahan; James Francis ; et al. | 2008-04-24 |
| Novel Compounds App 20080051416 - Boehm; Jeffrey Charles ; et al. | 2008-02-28 |
| Novel compounds App 20060211727 - Boehm; Jeffrey Charles ; et al. | 2006-09-21 |
| Calcilytic compounds Grant 7,109,238 - Lago , et al. September 19, 2 | 2006-09-19 |
| Calcilytic compounds App 20060058391 - Marquis; RobertW ; et al. | 2006-03-16 |
| Vitronectin receptor antagonists Grant 6,825,188 - Callahan , et al. November 30, 2 | 2004-11-30 |
| Calcilytic compounds App 20040192741 - Lago, Maria Amparo ; et al. | 2004-09-30 |
| Vitronectin receptor antagonists App 20040082559 - Callahan, James Francis ; et al. | 2004-04-29 |
| Vitronectin receptor antagonists App 20030125317 - Callahan, James Francis ; et al. | 2003-07-03 |
| Calcilytic compounds App 20030018203 - Largo, Maria Amparo ; et al. | 2003-01-23 |
| Calcilytic compounds and method of use App 20020052509 - Bhatnagar, Pradip Kumar ; et al. | 2002-05-02 |
| Calcilytic compounds Grant 6,294,531 - Barmore , et al. September 25, 2 | 2001-09-25 |
| Bicyclic fibrinogen antagonists Grant 6,117,910 - Callahan , et al. September 12, 2 | 2000-09-12 |
| Bicyclic fibrinogen antagonists Grant 5,693,636 - Bondinell , et al. December 2, 1 | 1997-12-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 